Search companies

Live

XENITRA LIMITED (ASX: XEN)

Consumer discretionary · News and insights

Price unavailable

Latest XEN announcements

Xenitra Highlights Pharmaceutical and Web3 Growth Plans After September-Quarter Sales

2026-11-06 · Consumer discretionary

XEN: $0.002 +0.00% · MC: $14M

Xenitra’s November investor presentation outlines plans to expand its pharmaceutical and Web3 commerce businesses, following September-quarter pharmaceutical sales of approximately $864,000 and more than $2 million in Web3 sales since April, as reported in its recent quarterly update. The presentation describes pharmaceutical margin potential of 20% to 40% and Web3 margins of 40% to 90%; these are stated profiles, not reported realised margins.

Updated 2026-11-06 12:01
Share
SourcesInvestor Presentation - November 2026
Comments

Xenitra Returns To Quarterly Gross Profit As Pharmaceuticals Launch

2026-10-30 · Consumer discretionary

XEN: $0.002 +0.00% · MC: $14M

Xenitra reported positive quarterly gross profit, reversing a loss in the same quarter last year, as its newly operational pharmaceuticals division generated approximately $864,000 in sales. The company says its three-year procurement agreements provide for at least $12 million in purchases and target a further $5 million, while Web3 partnerships have supported more than $2 million in sales since April. Quarter-end bank cash rose 9% from June and more than doubled year on year to approximately $3 million.

Updated 2026-10-30 16:42
Share
SourcesQuarterly Activities/Appendix 4C Cash Flow Report
Comments